Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 601 AL 615

T Cells Trafficking into the Brain in Aging and Alzheimer's Disease

Ma YZ, Cao JX, Zhang YS, Su XM, Jing YH, Gao LP.

J Neuroimmune Pharmacol. 2024 Aug 24;19(1):47. doi: 10.1007/s11481-024-10147-5.

Astrocyte-Neuron Interactions in Alzheimer's Disease

Muñoz-Castro C, Serrano-Pozo A.

Adv Neurobiol. 2024;39:345-382. doi: 10.1007/978-3-031-64839-7_14.

Vascular Function and Ion Channels in Alzheimer's Disease

Taylor JL, Martin-Aragon Baudel M, Nieves-Cintron M, Navedo MF.

Microcirculation. 2024 Oct;31(7):e12881. doi: 10.1111/micc.12881. Epub 2024 Aug 27.

Inflammatory aspects of Alzheimer's disease

Botella Lucena P, Heneka MT.

Acta Neuropathol. 2024 Aug 28;148(1):31. doi: 10.1007/s00401-024-02790-2.

Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors

Chowdari Gurram P, Satarker S, Nampoothiri M.

Biochem Biophys Res Commun. 2024 Nov 12;733:150597. doi: 10.1016/j.bbrc.2024.150597. Epub 2024 Aug 23.

Approved drugs and natural products at clinical stages for treating Alzheimer's disease

Ma Y, Liu S, Zhou Q, Li Z, Zhang Z, Yu B.

Chin J Nat Med. 2024 Aug;22(8):699-710. doi: 10.1016/S1875-5364(24)60606-0.

Interconnections between the Gut Microbiome and Alzheimer's Disease: Mechanisms and Therapeutic Potential

Sait AM, Day PJR.

Int J Mol Sci. 2024 Aug 7;25(16):8619. doi: 10.3390/ijms25168619.

A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research

Tyrakis P, Agridi C, Kourti M.

Int J Mol Sci. 2024 Aug 7;25(16):8630. doi: 10.3390/ijms25168630.

The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases

Kryńska K, Kuliś K, Mazurek W, Gudowska-Sawczuk M, Zajkowska M, Mroczko B.

Int J Mol Sci. 2024 Aug 9;25(16):8715. doi: 10.3390/ijms25168715.

Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy

Cipriano GL, Mazzon E, Anchesi I.

Int J Mol Sci. 2024 Aug 21;25(16):9077. doi: 10.3390/ijms25169077.

Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions

Joshi N, Vaidya B, Sharma SS.

Basic Clin Pharmacol Toxicol. 2024 Oct;135(4):375-400. doi: 10.1111/bcpt.14073. Epub 2024 Aug 29.

Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer's disease: a meta-analysis

Wang H, Li S, Zhang J, Peng W, Li T, Zhang J.

Eur J Med Res. 2024 Aug 29;29(1):438. doi: 10.1186/s40001-024-02006-z.

Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events

Wei W, Jiang Y, Hu G, He Y, Chen H.

J Alzheimers Dis. 2024;101(2):379-396. doi: 10.3233/JAD-240092.

Understanding the Human Being from a Quantum Perspective: Lessons to Elucidate Alzheimer's Disease Pathogenesis

Maccioni RB, Prieto R.

J Alzheimers Dis. 2024;101(3):735-736. doi: 10.3233/JAD-240864.

Management of Alzheimer's disease and related neurotoxic pathologies: Role of thiamine, pyridoxine and cobalamin

Ekundayo BE, Adewale OB, Obafemi BA, Afolabi OB, Obafemi TO.

Eur J Pharmacol. 2024 Nov 5;982:176958. doi: 10.1016/j.ejphar.2024.176958. Epub 2024 Aug 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias